AKT1 and lymphoma: PTEN is a ubiquitous tumor suppressor phosphatase known to inhibit pi3k/AKT which plays an important role in normal and malignant B cell biology affecting BCR signaling and downstream pathways affecting proliferation, differentiation and survival; pi3k/AKT serves as an attractive target in lymphoma therapy [35].